BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Buttó LF, Schaubeck M, Haller D. Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection. Front Immunol 2015;6:555. [PMID: 26635787 DOI: 10.3389/fimmu.2015.00555] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Peters SL, Morowitz MJ, Hettich RL. Antibiotic resistance and host immune system-induced metal bactericidal control are key factors for microbial persistence in the developing human preterm infant gut microbiome. Front Microbiol 2022;13. [DOI: 10.3389/fmicb.2022.958638] [Reference Citation Analysis]
2 Xu Z, Chen JJ, Mei Q, Li Y, Xu J. Expression of 5-hydroxytryptamine 7 receptor in intestinal mucosa correlates with the degree of intestinal inflammation in Crohn’s disease. BMC Gastroenterol 2022;22:457. [DOI: 10.1186/s12876-022-02513-5] [Reference Citation Analysis]
3 Zhao H, Zhang W, Cheng D, You L, Huang Y, Lu Y. Investigating dysbiosis and microbial treatment strategies in inflammatory bowel disease based on two modified Koch’s postulates. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1023896] [Reference Citation Analysis]
4 Özsoy M, Stummer N, Zimmermann FA, Feichtinger RG, Sperl W, Weghuber D, Schneider AM. Role of Energy Metabolism and Mitochondrial Function in Inflammatory Bowel Disease. Inflamm Bowel Dis 2022;28:1443-50. [PMID: 35247048 DOI: 10.1093/ibd/izac024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Beyi AF, Wannemuehler M, Plummer PJ. Impacts of Gut Microbiota on the Immune System and Fecal Microbiota Transplantation as a Re-Emerging Therapy for Autoimmune Diseases. Antibiotics 2022;11:1093. [DOI: 10.3390/antibiotics11081093] [Reference Citation Analysis]
6 Metwaly A, Jovic J, Waldschmitt N, Khaloian S, Heimes H, Häcker D, Hammoudi N, Bourhis LL, Mayorgas A, Siebert K, Basic M, Schwerd T, Allez M, Panes J, Salas A, Bleich A, Zeissig S, Schnupf P, Cominelli F, Haller D. Diet prevents the expansion of segmented filamentous bacteria and ileo-colonic inflammation in a model of Crohn’s disease.. [DOI: 10.1101/2022.07.06.498810] [Reference Citation Analysis]
7 Metwaly A, Reitmeier S, Haller D. Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders. Nat Rev Gastroenterol Hepatol 2022;19:383-97. [PMID: 35190727 DOI: 10.1038/s41575-022-00581-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 20.0] [Reference Citation Analysis]
8 Brichová M, Svozílková P, Klímová A, Dušek O, Kverka M, Heissigerová J. Microbiome and Uveitides. A Review. CSO 2022;78:47-52. [DOI: 10.31348/2021/30] [Reference Citation Analysis]
9 Chandra H, Sharma KK, Tuovinen OH, Sun X, Shukla P. Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile. Gut Microbes 2021;13:1979882. [PMID: 34724858 DOI: 10.1080/19490976.2021.1979882] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
10 Kapfhammer H. Gastrointestinale Erkrankungen. Depression, Angst, traumatischer Stress und internistische Erkrankungen 2022. [DOI: 10.1007/978-3-662-65873-4_6] [Reference Citation Analysis]
11 Maden SF, Acuner SE. Mapping Transcriptome Data to Protein-Protein Interaction Networks of Inflammatory Bowel Diseases Reveals Disease-Specific Subnetworks. Front Genet 2021;12:688447. [PMID: 34484291 DOI: 10.3389/fgene.2021.688447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Barlow J. Letter to the Editor: Comments on “Mammary microbial dysbiosis leads to the zoonosis of bovine mastitis: a One-Health perspective” by Maity and Ambatipudi. FEMS Microbiol Ecol 2021:fiab078. [PMID: 34100913 DOI: 10.1093/femsec/fiab078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Maity S, Ambatipudi K. Response to Comments on “Mammary microbial dysbiosis leads to the zoonosis of bovine mastitis: a One-Health perspective” by Maity and Ambatipudi. FEMS Microbiol Ecol 2021:fiab079. [PMID: 34100931 DOI: 10.1093/femsec/fiab079] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Maity S, Ambatipudi K. Mammary microbial dysbiosis leads to the zoonosis of bovine mastitis: a One-Health perspective. FEMS Microbiol Ecol 2020;97:fiaa241. [PMID: 33242081 DOI: 10.1093/femsec/fiaa241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
15 Ahmed M, Metwaly A, Haller D. Modeling microbe-host interaction in the pathogenesis of Crohn's disease. Int J Med Microbiol 2021;311:151489. [PMID: 33676240 DOI: 10.1016/j.ijmm.2021.151489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Carroll-Portillo A, Lin HC. Exploring Mucin as Adjunct to Phage Therapy. Microorganisms 2021;9:509. [PMID: 33670927 DOI: 10.3390/microorganisms9030509] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
17 Martin-Gallausiaux C, Malabirade A, Habier J, Wilmes P. Fusobacterium nucleatum Extracellular Vesicles Modulate Gut Epithelial Cell Innate Immunity via FomA and TLR2. Front Immunol 2020;11:583644. [PMID: 33408714 DOI: 10.3389/fimmu.2020.583644] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
18 Thomann AK, Mak JWY, Zhang JW, Wuestenberg T, Ebert MP, Sung JJY, Bernstein ÇN, Reindl W, Ng SC. Review article: bugs, inflammation and mood-a microbiota-based approach to psychiatric symptoms in inflammatory bowel diseases. Aliment Pharmacol Ther 2020;52:247-66. [PMID: 32525605 DOI: 10.1111/apt.15787] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
19 Drozdov VN, Arefev KI, Serebrova SY, Shikh EV. Clinical efficacy of drugs based on probiotic strains of Saccharomyces boulardii. Medicinskij sovet 2020. [DOI: 10.21518/2079-701x-2020-5-104-112] [Reference Citation Analysis]
20 Jackson DN, Theiss AL. Gut bacteria signaling to mitochondria in intestinal inflammation and cancer. Gut Microbes 2020;11:285-304. [PMID: 30913966 DOI: 10.1080/19490976.2019.1592421] [Cited by in Crossref: 96] [Cited by in F6Publishing: 99] [Article Influence: 32.0] [Reference Citation Analysis]
21 Uchida AM, Boden EK, James EA, Shows DM, Konecny AJ, Lord JD. Escherichiacoli-Specific CD4+ T Cells Have Public T-Cell Receptors and Low Interleukin 10 Production in Crohn's Disease. Cell Mol Gastroenterol Hepatol 2020;10:507-26. [PMID: 32361018 DOI: 10.1016/j.jcmgh.2020.04.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
22 Fan HN, Zhu P, Lu YM, Guo JH, Zhang J, Qu GQ, Zhu JS. Mild changes in the mucosal microbiome during terminal ileum inflammation. Microb Pathog 2020;142:104104. [PMID: 32120004 DOI: 10.1016/j.micpath.2020.104104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
23 Rowan-Nash AD, Araos R, D'Agata EMC, Belenky P. Antimicrobial Resistance Gene Prevalence in a Population of Patients with Advanced Dementia Is Related to Specific Pathobionts. iScience 2020;23:100905. [PMID: 32106056 DOI: 10.1016/j.isci.2020.100905] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
24 Stolzer I, Kaden-Volynets V, Ruder B, Letizia M, Bittel M, Rausch P, Basic M, Bleich A, Baines JF, Neurath MF, Wirtz S, Weidinger C, Bischoff SC, Becker C, Günther C. Environmental Microbial Factors Determine the Pattern of Inflammatory Lesions in a Murine Model of Crohn's Disease-Like Inflammation. Inflamm Bowel Dis 2020;26:66-79. [PMID: 31276162 DOI: 10.1093/ibd/izz142] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
25 Yu Y, Yang W, Li Y, Cong Y. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases. Inflamm Bowel Dis 2020;26:11-20. [PMID: 31560044 DOI: 10.1093/ibd/izz217] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 14.7] [Reference Citation Analysis]
26 Connors J, Dunn KA, Allott J, Bandsma R, Rashid M, Otley AR, Bielawski JP, Van Limbergen J. The relationship between fecal bile acids and microbiome community structure in pediatric Crohn's disease. ISME J 2020;14:702-13. [PMID: 31796936 DOI: 10.1038/s41396-019-0560-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 10.8] [Reference Citation Analysis]
27 Song X, Li J, Wang Y, Zhou C, Zhang Z, Shen M, Xiang P, Zhang X, Zhao H, Yu L, Zuo L, Hu J. Clematichinenoside AR ameliorated spontaneous colitis in Il-10-/- mice associated with improving the intestinal barrier function and abnormal immune responses. Life Sci 2019;239:117021. [PMID: 31678552 DOI: 10.1016/j.lfs.2019.117021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
28 Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome. Pathogens 2019;8:E126. [PMID: 31412603 DOI: 10.3390/pathogens8030126] [Cited by in Crossref: 251] [Cited by in F6Publishing: 269] [Article Influence: 62.8] [Reference Citation Analysis]
29 Hirschberg S, Gisevius B, Duscha A, Haghikia A. Implications of Diet and The Gut Microbiome in Neuroinflammatory and Neurodegenerative Diseases. Int J Mol Sci 2019;20:E3109. [PMID: 31242699 DOI: 10.3390/ijms20123109] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 12.5] [Reference Citation Analysis]
30 Lengfelder I, Sava IG, Hansen JJ, Kleigrewe K, Herzog J, Neuhaus K, Hofmann T, Sartor RB, Haller D. Complex Bacterial Consortia Reprogram the Colitogenic Activity of Enterococcus faecalis in a Gnotobiotic Mouse Model of Chronic, Immune-Mediated Colitis. Front Immunol 2019;10:1420. [PMID: 31281321 DOI: 10.3389/fimmu.2019.01420] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 6.8] [Reference Citation Analysis]
31 Baj A, Moro E, Bistoletti M, Orlandi V, Crema F, Giaroni C. Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis. Int J Mol Sci 2019;20:E1482. [PMID: 30934533 DOI: 10.3390/ijms20061482] [Cited by in Crossref: 100] [Cited by in F6Publishing: 104] [Article Influence: 25.0] [Reference Citation Analysis]
32 Tlaskalová Hogenová H, Jirásková Zákostelská Z, Petanová J, Kverka M. Microbiota, immunity and immunologically-mediated diseases. Vnitr Lek 2019;65:98-107. [DOI: 10.36290/vnl.2019.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Buret AG, Motta JP, Allain T, Ferraz J, Wallace JL. Pathobiont release from dysbiotic gut microbiota biofilms in intestinal inflammatory diseases: a role for iron? J Biomed Sci 2019;26:1. [PMID: 30602371 DOI: 10.1186/s12929-018-0495-4] [Cited by in Crossref: 90] [Cited by in F6Publishing: 94] [Article Influence: 22.5] [Reference Citation Analysis]
34 Armstrong H, Alipour M, Valcheva R, Bording-Jorgensen M, Jovel J, Zaidi D, Shah P, Lou Y, Ebeling C, Mason AL, Lafleur D, Jerasi J, Wong GK, Madsen K, Carroll MW, Huynh HQ, Dieleman LA, Wine E. Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases. Microbiome 2019;7:1. [PMID: 30606251 DOI: 10.1186/s40168-018-0604-3] [Cited by in Crossref: 97] [Cited by in F6Publishing: 103] [Article Influence: 24.3] [Reference Citation Analysis]
35 Renouf MJ, Cho YH, McPhee JB. Emergent Behavior of IBD-Associated Escherichia coli During Disease. Inflamm Bowel Dis 2019;25:33-44. [PMID: 30321333 DOI: 10.1093/ibd/izy312] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
36 Sakamaki A, Takamura M, Terai S. Microbiome in Liver Cirrhosis. The Evolving Landscape of Liver Cirrhosis Management 2019. [DOI: 10.1007/978-981-13-7979-6_7] [Reference Citation Analysis]
37 Bennek E, Mandić AD, Verdier J, Roubrocks S, Pabst O, Van Best N, Benz I, Kufer T, Trautwein C, Sellge G. Subcellular antigen localization in commensal E. coli is critical for T cell activation and induction of specific tolerance. Mucosal Immunol 2019;12:97-107. [PMID: 30327531 DOI: 10.1038/s41385-018-0061-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
38 Robino P, Ferrocino I, Rossi G, Dogliero A, Alessandria V, Grosso L, Galosi L, Tramuta C, Cocolin L, Nebbia P. Changes in gut bacterial communities in canaries infected by Macrorhabdus ornithogaster. Avian Pathol 2019;48:111-20. [PMID: 30499334 DOI: 10.1080/03079457.2018.1553294] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
39 Aoe S, Nakamura F, Fujiwara S. Effect of Wheat Bran on Fecal Butyrate-Producing Bacteria and Wheat Bran Combined with Barley on Bacteroides Abundance in Japanese Healthy Adults. Nutrients 2018;10:E1980. [PMID: 30558159 DOI: 10.3390/nu10121980] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
40 Li Z, Buttó LF, Buela KA, Jia LG, Lam M, Ward JD, Pizarro TT, Cominelli F. Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis. Front Immunol 2018;9:362. [PMID: 29545797 DOI: 10.3389/fimmu.2018.00362] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
41 Reinoso Webb C, den Bakker H, Koboziev I, Jones-Hall Y, Rao Kottapalli K, Ostanin D, Furr KL, Mu Q, Luo XM, Grisham MB. Differential Susceptibility to T Cell-Induced Colitis in Mice: Role of the Intestinal Microbiota. Inflamm Bowel Dis 2018;24:361-79. [PMID: 29361089 DOI: 10.1093/ibd/izx014] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 8.4] [Reference Citation Analysis]
42 Coleman OI, Haller D. Bacterial Signaling at the Intestinal Epithelial Interface in Inflammation and Cancer. Front Immunol 2017;8:1927. [PMID: 29354132 DOI: 10.3389/fimmu.2017.01927] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
43 Bergmeier LA, Fortune F. Non-infectious Diseases of the Oral Mucosa: The Importance of Immune Functions. Oral Mucosa in Health and Disease 2018. [DOI: 10.1007/978-3-319-56065-6_11] [Reference Citation Analysis]
44 Elderman M, Sovran B, Hugenholtz F, Graversen K, Huijskes M, Houtsma E, Belzer C, Boekschoten M, de Vos P, Dekker J, Wells J, Faas M. The effect of age on the intestinal mucus thickness, microbiota composition and immunity in relation to sex in mice. PLoS One 2017;12:e0184274. [PMID: 28898292 DOI: 10.1371/journal.pone.0184274] [Cited by in Crossref: 52] [Cited by in F6Publishing: 68] [Article Influence: 8.7] [Reference Citation Analysis]
45 Sivaprakasam S, Bhutia YD, Ramachandran S, Ganapathy V. Cell-Surface and Nuclear Receptors in the Colon as Targets for Bacterial Metabolites and Its Relevance to Colon Health. Nutrients 2017;9:E856. [PMID: 28796169 DOI: 10.3390/nu9080856] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
46 Selber-Hnatiw S, Rukundo B, Ahmadi M, Akoubi H, Al-Bizri H, Aliu AF, Ambeaghen TU, Avetisyan L, Bahar I, Baird A, Begum F, Ben Soussan H, Blondeau-Éthier V, Bordaries R, Bramwell H, Briggs A, Bui R, Carnevale M, Chancharoen M, Chevassus T, Choi JH, Coulombe K, Couvrette F, D'Abreau S, Davies M, Desbiens MP, Di Maulo T, Di Paolo SA, Do Ponte S, Dos Santos Ribeiro P, Dubuc-Kanary LA, Duncan PK, Dupuis F, El-Nounou S, Eyangos CN, Ferguson NK, Flores-Chinchilla NR, Fotakis T, Gado Oumarou H D M, Georgiev M, Ghiassy S, Glibetic N, Grégoire Bouchard J, Hassan T, Huseen I, Ibuna Quilatan MF, Iozzo T, Islam S, Jaunky DB, Jeyasegaram A, Johnston MA, Kahler MR, Kaler K, Kamani C, Karimian Rad H, Konidis E, Konieczny F, Kurianowicz S, Lamothe P, Legros K, Leroux S, Li J, Lozano Rodriguez ME, Luponio-Yoffe S, Maalouf Y, Mantha J, McCormick M, Mondragon P, Narayana T, Neretin E, Nguyen TTT, Niu I, Nkemazem RB, O'Donovan M, Oueis M, Paquette S, Patel N, Pecsi E, Peters J, Pettorelli A, Poirier C, Pompa VR, Rajen H, Ralph RO, Rosales-Vasquez J, Rubinshtein D, Sakr S, Sebai MS, Serravalle L, Sidibe F, Sinnathurai A, Soho D, Sundarakrishnan A, Svistkova V, Ugbeye TE, Vasconcelos MS, Vincelli M, Voitovich O, Vrabel P, Wang L, Wasfi M, Zha CY, Gamberi C. Human Gut Microbiota: Toward an Ecology of Disease. Front Microbiol 2017;8:1265. [PMID: 28769880 DOI: 10.3389/fmicb.2017.01265] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 13.3] [Reference Citation Analysis]
47 Buttó LF, Haller D. Functional relevance of microbiome signatures: The correlation era requires tools for consolidation. Journal of Allergy and Clinical Immunology 2017;139:1092-8. [DOI: 10.1016/j.jaci.2017.02.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
48 Zechner EL. Inflammatory disease caused by intestinal pathobionts. Current Opinion in Microbiology 2017;35:64-9. [DOI: 10.1016/j.mib.2017.01.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
49 Sartor RB, Wu GD. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. Gastroenterology 2017;152:327-339.e4. [PMID: 27769810 DOI: 10.1053/j.gastro.2016.10.012] [Cited by in Crossref: 470] [Cited by in F6Publishing: 484] [Article Influence: 78.3] [Reference Citation Analysis]
50 Buttó LF, Haller D. Dysbiosis in Crohn's disease - Joint action of stochastic injuries and focal inflammation in the gut. Gut Microbes 2017;8:53-8. [PMID: 28102757 DOI: 10.1080/19490976.2016.1270810] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
51 Alhagamhmad MH, Day AS, Lemberg DA, Leach ST. An overview of the bacterial contribution to Crohn disease pathogenesis. Journal of Medical Microbiology 2016;65:1049-59. [DOI: 10.1099/jmm.0.000331] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
52 Schüppel V, Haller D. Das Mikrobiom bei chronischen Erkrankungen. Diabetologe 2016;12:420-427. [DOI: 10.1007/s11428-016-0124-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Basson A, Trotter A, Rodriguez-Palacios A, Cominelli F. Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease. Front Immunol. 2016;7:290. [PMID: 27531998 DOI: 10.3389/fimmu.2016.00290] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 10.7] [Reference Citation Analysis]
54 Lobatón T, Domènech E. Bacterial Intestinal Superinfections in Inflammatory Bowel Diseases Beyond Clostridum difficile. Inflamm Bowel Dis 2016;22:1755-62. [PMID: 27104824 DOI: 10.1097/MIB.0000000000000788] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
55 Egan S, Gardiner M. Microbial Dysbiosis: Rethinking Disease in Marine Ecosystems. Front Microbiol 2016;7:991. [PMID: 27446031 DOI: 10.3389/fmicb.2016.00991] [Cited by in Crossref: 108] [Cited by in F6Publishing: 122] [Article Influence: 15.4] [Reference Citation Analysis]
56 Buttó LF, Haller D. Dysbiosis in intestinal inflammation: Cause or consequence. Int J Med Microbiol 2016;306:302-9. [PMID: 27012594 DOI: 10.1016/j.ijmm.2016.02.010] [Cited by in Crossref: 90] [Cited by in F6Publishing: 94] [Article Influence: 12.9] [Reference Citation Analysis]